Features
Latest Features
The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction
A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.
Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
Current research suggests patients with pulmonary arterial hypertension may benefit from iron and vitamin D supplementation.
Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin
To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.
Unraveling the Relationship Between COPD and Stroke
Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.
Managing Cardiovascular Risk in Rheumatoid Cachexia
Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.
Improving Risk Stratification, Diagnostic Accuracy in PAH With Cardiopulmonary Exercise Testing
Cardiopulmonary exercise testing can be an important diagnostic and prognostic tool in pulmonary arterial hypertension.
Should Physicians Treat Family and Friends? Three Experts Weigh In
Although all of the guidelines acknowledge that there are emergent situations in which providing care for a family member or friend is not only permissible but also essential, other situations are frowned upon.
Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes
Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.
How Many Chances Are Too Many? Treating Recurrent Infective Endocarditis in IV Drug Users
How many second chances should a drug user get? As many as it takes for us — physicians, society, government, and the healthcare system — to get it right.
Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE
Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.
Improved Pulmonary Arterial Hypertension Risk Prediction Tools Needed
The use of a risk calculator aimed at achieving a low-risk profile in PAH trials is discussed.
What a Building Contractor Taught Me About Informed Consent
Identifying a patient's preferences and goals leads to a care plan that can reflect those goals, and this may improve patient satisfaction.
The Unintended Consequences of Cigarette Taxation
Although cigarette taxes were supposedly implemented to encourage smokers to quit, they can have a disproportionate effect on people of low-income status.
Under the Microscope: Medicine's #MeToo Moment
No single solution to address sexual harassment in medicine exists, but physicians of all genders must come together to make progress.
Breathing New Life Into COPD and Asthma Therapy With Statins
Statins have anti-inflammatory and anti-oxidative effects, which could reduce exacerbations of both asthma and chronic obstructive pulmonary disease.
Bully for Us: Confronting Medicine's Bullying Problem
The culture of bullying — widespread across the medical field — has been linked to poorer patient outcomes. So why can't physicians stop bullying in its tracks?
AHA Examines CVD and Breast Cancer Relationship
The American Heart Association has released a scientific statement examining the relationship between cardiovascular disease and breast cancer.
Blood Pressure Targets in Type 2 Diabetes: Latest Research
Experts call on healthcare providers to diligently focus on hypertension as an important comorbid condition that is strongly associated with adverse cardiovascular outcomes, including death.
The Mounting Evidence Against Electronic Cigarette Use
Electronic cigarettes were once thought to be a helpful smoking cessation tool, but new evidence suggests they may be as if not more harmful than combustible cigarettes.
Antidiabetic Drugs and Cardiovascular Risk: Expert Perspectives
Although many of the newer antidiabetic drugs have demonstrated favorable outcomes in clinical trials, some have also been associated with increased risk of adverse CV outcomes.
The Cardiology Advisor Articles
- Concomitant NSAID and Anticoagulant Use May Increase Stroke, Bleeding Risk in Afib
- Hypothyroidism Predicts Atrial Tachyarrhythmia After AF Catheter Ablation
- USPSTF Does Not Recommend Afib Screening in Asymptomatic Patients
- American Heart Association Urges Screen Time Limits for Youth
- Pulmonary-Systemic Pulse Pressure Ratio Linked to PH Mortality
- Thromboembolic Disorder Treatments: Without DVT/PE
- Apixaban Lowers Bleeding Risk in Afib With End-Stage Kidney Disease
- Tricuspid Regurgitation Velocity Unreliable Indicator of Pulmonary Hypertension
- Heart Failure Risk Increased When Sleep Apnea Not Managed With CPAP
- Thromboembolic Disorder Treatments: DVT/PE
- Perspectives on USPSTF Afib Screening Recommendation
- Generic Version of Adcirca Now Available for Pulmonary Arterial Hypertension
- Exercise Benefits for Myocardial Infarction Not Reduced by Traffic Pollutants
- Orenitram Decreased Risk of Morbidity/Mortality Event in PAH Trial
- Healthy Lifestyle With Diabetes Reduces Cardiovascular Risk